BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,099,000 | +3.7% | 20,500 | 0.0% | 0.53% | +9.3% |
Q2 2022 | $2,987,000 | +22.9% | 20,500 | 0.0% | 0.49% | +47.7% |
Q1 2022 | $2,431,000 | -13.9% | 20,500 | 0.0% | 0.33% | -7.6% |
Q4 2021 | $2,825,000 | -0.8% | 20,500 | 0.0% | 0.36% | -8.0% |
Q3 2021 | $2,848,000 | +43.1% | 20,500 | 0.0% | 0.39% | +46.0% |
Q2 2021 | $1,990,000 | +42.0% | 20,500 | 0.0% | 0.26% | +33.2% |
Q1 2021 | $1,401,000 | +8.9% | 20,500 | +36.7% | 0.20% | +0.5% |
Q4 2020 | $1,286,000 | +31.9% | 15,000 | 0.0% | 0.20% | +13.1% |
Q3 2020 | $975,000 | -11.1% | 15,000 | 0.0% | 0.18% | -15.0% |
Q2 2020 | $1,097,000 | +115.1% | 15,000 | 0.0% | 0.21% | +76.1% |
Q1 2020 | $510,000 | -37.6% | 15,000 | 0.0% | 0.12% | -15.8% |
Q4 2019 | $817,000 | +30.5% | 15,000 | 0.0% | 0.14% | +21.9% |
Q3 2019 | $626,000 | +138.0% | 15,000 | +150.0% | 0.11% | +142.6% |
Q2 2019 | $263,000 | – | 6,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |